Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J4RY
|
|||
Former ID |
DNC006608
|
|||
Drug Name |
BAS-450225
|
|||
Synonyms |
BAS-450225; CHEMBL210036; 2,4-dichloro-N-(5-phenethyl-1,3,4-thiadiazol-2-yl)benzamide; AC1LL38T; Oprea1_759762; Oprea1_195875
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H13Cl2N3OS
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CCC2=NN=C(S2)NC(=O)C3=C(C=C(C=C3)Cl)Cl
|
|||
InChI |
1S/C17H13Cl2N3OS/c18-12-7-8-13(14(19)10-12)16(23)20-17-22-21-15(24-17)9-6-11-4-2-1-3-5-11/h1-5,7-8,10H,6,9H2,(H,20,22,23)
|
|||
InChIKey |
BVZCHEPRCHHCRQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors. J Med Chem. 2006 Jun 1;49(11):3278-86. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.